Search

everythinglearnresearchcommunity

for

Search:↓

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Researchers identified five new potential targets for leishmaniasis treatment, suggesting repurposing existing drugs could be effective.

The study concludes that regulating apoptosis could lead to new treatments for various skin and hair conditions.

Microglia, the brain's immune cells, may contribute to Polycystic Ovary Syndrome (PCOS) by altering the female brain's structure and function, with kisspeptin neurons and GABA neurotransmitters also playing a role.

Male and female pattern hair loss have different molecular pathways, suggesting unique treatment targets for each sex.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

Certain metabolites can either protect against or increase the risk of hair loss.

Environmental pollutants can damage hair health and cause hair loss.

Testosterone in older women can increase bone density, muscle mass, fat mass, improve memory, and boost libido, but may cause nipple color changes.

Scalp needle mesotherapy can effectively treat hair loss and improve hair growth.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Aromatase gene variation may increase female hair loss risk.

Human skin produces sex hormones like estrogen and testosterone, influenced by ARO and StAR, which may affect skin elasticity and hair growth.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Aromatase inhibitors cause male pattern hair loss in women.

No link found between aromatase gene and female hair loss.

Letrozole reduces seizures but not brain damage in mice.

Some breast cancer treatments cause hair loss similar to male pattern baldness, which can be improved with minoxidil.

Two teenage boys lost hair after taking a drug for growth, which was not a known side effect for kids.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

A 12-year-old boy with PAIS successfully developed male characteristics using high-dose testosterone and anastrozole.

Certain medications can cause serious side effects, including skin reactions, stroke, muscle disorders, tongue swelling, hair loss in women, and liver failure.

Low-dose oral minoxidil improved hair growth when topical treatments failed.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

The effects of estrogen on human hair growth are unclear and need more research.